<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In 1987, a 50-year-old patient presented with isolated <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> (27,000/mm3) which proved to be refractory to steroid medication and high i.v. doses of immunoglobulin </plain></SENT>
<SENT sid="1" pm="."><plain>Two years later he developed <z:hpo ids='HP_0001972'>macrocytic anemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Chromosomal analysis confirmed the diagnosis of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> type with blast excess </plain></SENT>
<SENT sid="3" pm="."><plain>Cytogenetically, three cellular populations were observed: one <z:mpath ids='MPATH_458'>normal</z:mpath> (75% of metaphases) and two abnormal, clone A (2%) 46,XY, del(5q), del(11q), and clone B (23%) 46,XY, del(5q), del(11q) plus 2 other anomalies </plain></SENT>
<SENT sid="4" pm="."><plain>Evolution was characterized by worsening of the bicytopenia with marked <z:mpath ids='MPATH_133'>hypoplasia</z:mpath> of the megakaryocytic and erythroid series while the percentage of blasts remained stable </plain></SENT>
<SENT sid="5" pm="."><plain>Concerning the chromosomal markers, the <z:mpath ids='MPATH_458'>normal</z:mpath> population disappeared and clone A became predominant (clone A 97%, clone B 3%) </plain></SENT>
<SENT sid="6" pm="."><plain>This case shows that isolated <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> can be the sole initial manifestation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>We discuss the possibility that "refractory <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>" constitutes a diagnostic category like <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> or <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with ring sideroblasts </plain></SENT>
<SENT sid="8" pm="."><plain>The proliferative advantage of clone A or the disadvantage of clone B may be due to the occurrence of new, cytogenetically non-detectable mutations </plain></SENT>
</text></document>